Abed Yacine, Baz Mariana, Boivin Guy
Research Center in Infectious Diseases, Centre Hospitalier Universitaire de Québec-Centre Hospitalier de l'Université Laval and Laval University, Québec City, Québec, Canada.
J Infect Dis. 2009 Jan 15;199(2):180-3. doi: 10.1086/595736.
Neuraminidase (NA) mutations responsible for influenza resistance to oseltamivir vary according to the NA subtype; in influenza A/H3N2 viruses, NA-gene mutations occur predominantly at codons E119 and R292. In an oseltamivir-resistant influenza A/H3N2 virus isolated from an immunocompromised child after 107 days of cumulative treatment, the NA gene contained 3 aa substitutions (N146K, S219T, and A272V) and a 4-aa deletion (Del245-248); reversion mutation experiments using recombinant NA proteins determined that the deletion was the sole change responsible for resistance to oseltamivir. This study highlights the diversity of mechanisms of resistance to oseltamivir in clinical settings, reinforcing the need for novel anti-influenza strategies.
导致流感病毒对奥奥奥奥司他韦产生耐药性的神经氨酸酶(NA)突变因NA亚型而异;在甲型H3N2流感病毒中,NA基因突变主要发生在第119位密码子(E119)和第292位密码子(R292)。在一名免疫功能低下儿童接受107天累积治疗后分离出的一株对奥司他韦耐药的甲型H3N2流感病毒中,NA基因包含3个氨基酸替换(N146K、S219T和A272V)和一个4氨基酸缺失(Del245 - 248);使用重组NA蛋白进行的回复突变实验确定,该缺失是导致对奥司他韦耐药的唯一变化。这项研究突出了临床环境中奥司他韦耐药机制的多样性,强化了对新型抗流感策略的需求。